Condition: Intracranial Aneurysm · Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.
The purpose of this study is to assess how safe choydar flow-directed mesh stent is and how well it works in the treatment of unruptured intracranial aneurysms (a condition in which a bulging blood vessel in the brain can burst and cause bleeding) in a real-world setting.
This description comes directly from the study's public registry record.
Yuanyuan Gu · 86 15692105615 · ygu51@its.jnj.com
Always discuss trial participation with your own doctor first.
| Chenzhou No.1 People's Hospital | Chenzhou, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, China | Recruiting |
| Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School | Nanjing, China | Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, China | Recruiting |
| Nanyang Central Hospital | Nanyang, China | Recruiting |
| Shanxi Provincial People's Hospital | Taiyuan, China | Recruiting |
| The First Affiliated Hospital of Wannan Medical College | Wuhu, China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07228312